TY  - JOUR
AU  - Buxeda, Anna
AU  - Arias-Cabrales, Carlos
AU  - Pérez-Sáez, María José
AU  - Cacho, Judit
AU  - Cabello Pelegrin, Sheila
AU  - Melilli, Edoardo
AU  - Aladrén, María José
AU  - Galeano, Cristina
AU  - Lorenzo, Inmaculada
AU  - Mazuecos, Auxiliadora
AU  - Saura, Isabel María
AU  - Franco, Antonio
AU  - Ruiz-Fuentes, María Del Carmen
AU  - Sánchez-Cámara, Luis Alberto
AU  - Siverio, Orlando
AU  - Martin, María Luisa
AU  - González-García, Elena
AU  - López, Verónica
AU  - Martin-Moreno, Paloma Leticia
AU  - Moina, Iñigo
AU  - Moral Berrio, Esperanza
AU  - Moreso, Francesc
AU  - Portolés, José María
AU  - Santana-Estupiñán, Raquel
AU  - Zárraga, Sofía
AU  - Canal, Cristina
AU  - Sánchez-Álvarez, Emilio
AU  - Pascual, Julio
AU  - Crespo, Marta
PY  - 2021
DO  - 10.1016/j.ekir.2021.06.023
UR  - https://hdl.handle.net/10668/25745
T2  - Kidney international reports
AB  - Remdesivir has demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID-19. Severe adverse events such as acute kidney injury have been reported. Scant data are available on...
LA  - en
KW  - SARS-CoV2l
KW  - acute kidney injury
KW  - immunosuppression
KW  - kidney transplantation
KW  - remdesivir
TI  - Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19.
TY  - research article
VL  - 6
ER  -